Maple Grove, MN – May 16, 2023 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Dicyclomine Hydrochloride Capsules, USP 10 mg. The company now offers the product in tablet and capsule forms.
The dicyclomine ... Read More
Pending legislation misses the mark when targeting drug costs
As a Minnesota pharmaceutical company focused on making generic medications, Upsher-Smith’s mission is to provide America’s patients with high quality generic medication options that are cost effective. ... Read More
Maple Grove, MN – April 13, 2023 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced it has expanded its ophthalmic portfolio with the launch of Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, 0.2%/0.5%, an AB-rated generic ... Read More
Maple Grove, MN – April 11, 2023 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that Becky Jansen, Associate Vice President of Technical Services was recognized as a 2023 Notable Woman in STEM by Twin Cities ... Read More
Maple Grove, MN – April 3, 2023 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Fluphenazine Hydrochloride Tablets, USP in 1 mg, 2.5 mg, 5 mg, and 10 mg strengths. The fluphenazine hydrochloride ... Read More
Maple Grove, MN – March 13, 2023 – Upsher-Smith Laboratories, LLC (Upsher-Smith) was one of six Minnesota manufacturers recognized by Twin Cities Business as a 2023 recipient of its Manufacturing Excellence Award. All the honorees ... Read More
Maple Grove, MN – March 6, 2023 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Dicyclomine Hydrochloride Tablets, USP 20 mg. This product launch is a result of Upsher-Smith’s strategic partnership with CorePharma ... Read More
